Look ... down in the Bottom Line! It's a trend! It's a forecast! It's an advantage! It's SuperBook! If it was impactful news and happened over the past year, it's in here. If it has a bearing on new drug commercialization in this decade, it's in here!
The biotechnology market is approaching 40 and this is the decade in which it must come of age and claim the future that everyone has assigned it of becoming the premiere drug market in the world. This report gives you a heads up on the trends, products, deals, litigation, R&D, financials, successes, catastrophes and more that defined the biotech market in 2009. It also looks at the drugs that are taking the industry into its Golden Age future which promises to be the Age of Biotechnology, with an in-depth assessment of biotech's raison d' tre: its products.
We've beefed up the Annual Report with sector analyses, revenue projections, a timeline and more to augment the value you traditionally received. We've taken nothing out of the information that has made this a market summary best-seller for years, but we have added data and analysis that will surely increase its value to the reader.
BioWorld Biotech SuperBook: Vital Signs & The 2010 State of the Industry Report is priced at $499, plus $17.95 in shipping and handling.
Many issues confront the market as it grows closer to profitability and the $100 billion value level. This report gives you the acumen and data necessary for consideration in all your biotechnology business decision-making.
People who need this report include:
- Biotechnology and pharmaceutical executives
- Law firms serving the sector
- Economic development organizations
- Analysts and investors
- Attorneys and patent officers
- Research and development directors
- Technology transfer officers
- Competitive start-ups
Gathering this much information on your own would take more than a year, but we've done the legwork for you with our team of writers, researchers. All you have to do is use the business intelligence to your advantage.
The book is published with color highlighting and is laid out in column format for the first time, which makes for more convenient reading.
This report gives you the introspective overview on the happenings from the bench to Wall Street to Washington to Europe.
BioWorld Biotech SuperBook: Vital Signs & The 2010 State of the Industry Report can be purchased in print or PDF.
To view the table of contents, click here.
Print and PDF Version:
Report-Only Price: $499 (+ $17.95 s&h)